UK markets open in 7 hours 18 minutes
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.06 +0.06 (+0.08%) GOLD FUTURES
2,331.30 +20.30 (+0.88%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,371.62 -1,972.61 (-4.08%)
Swedish Orphan Biovitrum AB (publ) (SOBIS.XC)
Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
At close: 03:16PM BST
Currency in SEK
Valuation measures4
| Market cap (intra-day) | 97.00B |
| Enterprise value | 115.69B |
| Trailing P/E | 41.91 |
| Forward P/E | 26.18 |
| PEG ratio (5-yr expected) | 1.29 |
| Price/sales (ttm) | 3.82 |
| Price/book (mrq) | 2.51 |
| Enterprise value/revenue | 5.00 |
| Enterprise value/EBITDA | 15.85 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.26 |
| 52-week change 3 | 4.62% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 290.60 |
| 52-week low 3 | 185.25 |
| 50-day moving average 3 | 260.28 |
| 200-day moving average 3 | 242.27 |
Share statistics
| Avg vol (3-month) 3 | 14 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 339.87M |
| Implied shares outstanding 6 | 363.6M |
| Float 8 | 198.7M |
| % held by insiders 1 | 10.08% |
| % held by institutions 1 | 73.89% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 9.26% |
| Operating margin (ttm) | 23.47% |
Management effectiveness
| Return on assets (ttm) | 4.51% |
| Return on equity (ttm) | 6.72% |
Income statement
| Revenue (ttm) | 23.14B |
| Revenue per share (ttm) | 69.38 |
| Quarterly revenue growth (yoy) | 19.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 7.77B |
| Net income avi to common (ttm) | 2.14B |
| Diluted EPS (ttm) | 6.33 |
| Quarterly earnings growth (yoy) | -25.00% |
Balance sheet
| Total cash (mrq) | 527M |
| Total cash per share (mrq) | 1.55 |
| Total debt (mrq) | 19.22B |
| Total debt/equity (mrq) | 53.54% |
| Current ratio (mrq) | 0.71 |
| Book value per share (mrq) | 105.59 |
Cash flow statement
| Operating cash flow (ttm) | 4.74B |
| Levered free cash flow (ttm) | 2.69B |
© 2024 Yahoo. All rights reserved.